Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advanced Cancer Therapeutics, a biopharmaceutical company, has appointed Gilles Tapolsky as its new chief scientific officer.
Subscribe to our email newsletter
In this newly created position, Dr Tapolsky will be responsible for the leadership of all preclinical and clinical development activities.
Prior to joining Advanced Cancer Therapeutics, Dr Tapolsky served as vice president of product development at Tapestry Pharmaceuticals of Boulder, Colorado.
Dr Tapolsky earned his PhD in chemistry from the University of Paris and holds an MBA from Rice University.
Randall Riggs, president and CEO of Advanced Cancer Therapeutics, said: “We are thrilled to have Gilles join our team. He has led a distinguished career in pharmaceutical development and is recognized as a leader in the biotechnology field.”